The global semi-solid dosage contract manufacturing market size is calculated at USD 21.70 billion in 2025 and is forecasted to reach around USD 56.50 billion by 2034, accelerating at a CAGR of 11.22% from 2025 to 2034. The Asia Pacific market size surpassed USD 6.44 billion in 2024 and is expanding at a CAGR of 11.38% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Semi-Solid Dosage Contract Manufacturing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Semi-Solid Dosage Contract Manufacturing Market Revenue and Volume Forecast, by Type
8.1.1. Topical
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Transdermal
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Oral
8.1.3.1. Market Revenue and Volume Forecast
9.1. Semi-Solid Dosage Contract Manufacturing Market Revenue and Volume Forecast, by Product
9.1.1. Creams
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Ointments
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Gels
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Lotions
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Pastes
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast
10.1. Semi-Solid Dosage Contract Manufacturing Market Revenue and Volume Forecast, by Company Size
10.1.1. Large Size Companies
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Medium and Small Size Companies
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. Semi-Solid Dosage Contract Manufacturing Market Revenue and Volume Forecast, by End Use
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Cosmeceutical Companies
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type
12.1.2. Market Revenue and Volume Forecast, by Product
12.1.3. Market Revenue and Volume Forecast, by Company Size
12.1.4. Market Revenue and Volume Forecast, by End Use
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type
12.1.5.2. Market Revenue and Volume Forecast, by Product
12.1.5.3. Market Revenue and Volume Forecast, by Company Size
12.1.5.4. Market Revenue and Volume Forecast, by End Use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type
12.1.6.2. Market Revenue and Volume Forecast, by Product
12.1.6.3. Market Revenue and Volume Forecast, by Company Size
12.1.6.4. Market Revenue and Volume Forecast, by End Use
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type
12.2.2. Market Revenue and Volume Forecast, by Product
12.2.3. Market Revenue and Volume Forecast, by Company Size
12.2.4. Market Revenue and Volume Forecast, by End Use
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type
12.2.5.2. Market Revenue and Volume Forecast, by Product
12.2.5.3. Market Revenue and Volume Forecast, by Company Size
12.2.5.4. Market Revenue and Volume Forecast, by End Use
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type
12.2.6.2. Market Revenue and Volume Forecast, by Product
12.2.6.3. Market Revenue and Volume Forecast, by Company Size
12.2.6.4. Market Revenue and Volume Forecast, by End Use
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type
12.2.7.2. Market Revenue and Volume Forecast, by Product
12.2.7.3. Market Revenue and Volume Forecast, by Company Size
12.2.7.4. Market Revenue and Volume Forecast, by End Use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type
12.2.8.2. Market Revenue and Volume Forecast, by Product
12.2.8.3. Market Revenue and Volume Forecast, by Company Size
12.2.8.4. Market Revenue and Volume Forecast, by End Use
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type
12.3.2. Market Revenue and Volume Forecast, by Product
12.3.3. Market Revenue and Volume Forecast, by Company Size
12.3.4. Market Revenue and Volume Forecast, by End Use
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type
12.3.5.2. Market Revenue and Volume Forecast, by Product
12.3.5.3. Market Revenue and Volume Forecast, by Company Size
12.3.5.4. Market Revenue and Volume Forecast, by End Use
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type
12.3.6.2. Market Revenue and Volume Forecast, by Product
12.3.6.3. Market Revenue and Volume Forecast, by Company Size
12.3.6.4. Market Revenue and Volume Forecast, by End Use
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type
12.3.7.2. Market Revenue and Volume Forecast, by Product
12.3.7.3. Market Revenue and Volume Forecast, by Company Size
12.3.7.4. Market Revenue and Volume Forecast, by End Use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type
12.3.8.2. Market Revenue and Volume Forecast, by Product
12.3.8.3. Market Revenue and Volume Forecast, by Company Size
12.3.8.4. Market Revenue and Volume Forecast, by End Use
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type
12.4.2. Market Revenue and Volume Forecast, by Product
12.4.3. Market Revenue and Volume Forecast, by Company Size
12.4.4. Market Revenue and Volume Forecast, by End Use
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type
12.4.5.2. Market Revenue and Volume Forecast, by Product
12.4.5.3. Market Revenue and Volume Forecast, by Company Size
12.4.5.4. Market Revenue and Volume Forecast, by End Use
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type
12.4.6.2. Market Revenue and Volume Forecast, by Product
12.4.6.3. Market Revenue and Volume Forecast, by Company Size
12.4.6.4. Market Revenue and Volume Forecast, by End Use
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type
12.4.7.2. Market Revenue and Volume Forecast, by Product
12.4.7.3. Market Revenue and Volume Forecast, by Company Size
12.4.7.4. Market Revenue and Volume Forecast, by End Use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type
12.4.8.2. Market Revenue and Volume Forecast, by Product
12.4.8.3. Market Revenue and Volume Forecast, by Company Size
12.4.8.4. Market Revenue and Volume Forecast, by End Use
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type
12.5.2. Market Revenue and Volume Forecast, by Product
12.5.3. Market Revenue and Volume Forecast, by Company Size
12.5.4. Market Revenue and Volume Forecast, by End Use
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type
12.5.5.2. Market Revenue and Volume Forecast, by Product
12.5.5.3. Market Revenue and Volume Forecast, by Company Size
12.5.5.4. Market Revenue and Volume Forecast, by End Use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type
12.5.6.2. Market Revenue and Volume Forecast, by Product
12.5.6.3. Market Revenue and Volume Forecast, by Company Size
12.5.6.4. Market Revenue and Volume Forecast, by End Use
13.1. Lonza Group Ltd
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerTypeance
13.1.4. Recent Initiatives
13.2. Lubrizol Life Science
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerTypeance
13.2.4. Recent Initiatives
13.3. Cambrex Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerTypeance
13.3.4. Recent Initiatives
13.4. Contract Pharmaceuticals Limited
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerTypeance
13.4.4. Recent Initiatives
13.5. Bora Pharmaceutical CDMO
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerTypeance
13.5.4. Recent Initiatives
13.6. Ascendia Pharmaceuticals
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerTypeance
13.6.4. Recent Initiatives
13.7. Pierre Fabre group
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerTypeance
13.7.4. Recent Initiatives
13.8. Piramal Pharma Solutions
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerTypeance
13.8.4. Recent Initiatives
13.9. DPT Laboratories, LTD
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerTypeance
13.9.4. Recent Initiatives
13.10. MedPharm Ltd
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerTypeance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample